Harbor Capital Advisors Inc. Decreases Stake in Healthpeak Properties, Inc. (NYSE:DOC)

Harbor Capital Advisors Inc. decreased its position in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 90.6% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 2,172 shares of the real estate investment trust's stock after selling 20,902 shares during the period. Harbor Capital Advisors Inc.'s holdings in Healthpeak Properties were worth $44,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in DOC. Mizuho Bank Ltd. bought a new position in Healthpeak Properties in the 4th quarter worth approximately $28,000. Harvest Fund Management Co. Ltd bought a new position in Healthpeak Properties in the 4th quarter worth approximately $30,000. Future Financial Wealth Managment LLC bought a new position in Healthpeak Properties in the 1st quarter worth approximately $30,000. Covestor Ltd boosted its holdings in Healthpeak Properties by 173.8% in the 4th quarter. Covestor Ltd now owns 1,815 shares of the real estate investment trust's stock worth $37,000 after buying an additional 1,152 shares during the period. Finally, Kestra Investment Management LLC bought a new position in Healthpeak Properties in the 4th quarter worth approximately $45,000. Hedge funds and other institutional investors own 93.57% of the company's stock.

Insider Transactions at Healthpeak Properties

In related news, Director Tommy G. Thompson bought 5,700 shares of the stock in a transaction dated Friday, May 9th. The stock was bought at an average price of $17.36 per share, with a total value of $98,952.00. Following the purchase, the director now owns 138,513 shares in the company, valued at approximately $2,404,585.68. The trade was a 4.29% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at this link. Also, Director John T. Thomas bought 4,200 shares of the stock in a transaction dated Monday, April 28th. The stock was bought at an average cost of $17.84 per share, with a total value of $74,928.00. Following the purchase, the director now owns 813,566 shares in the company, valued at $14,514,017.44. The trade was a 0.52% increase in their position. The disclosure for this purchase can be found here. In the last three months, insiders bought 29,764 shares of company stock worth $521,909. 0.23% of the stock is currently owned by corporate insiders.

Healthpeak Properties Trading Down 0.7%

Shares of DOC stock opened at $17.38 on Monday. The business has a 50-day moving average price of $17.73 and a two-hundred day moving average price of $19.40. Healthpeak Properties, Inc. has a 12-month low of $16.64 and a 12-month high of $23.26. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 0.96. The firm has a market cap of $12.07 billion, a P/E ratio of 49.64, a price-to-earnings-growth ratio of 2.17 and a beta of 1.04.

Healthpeak Properties (NYSE:DOC - Get Free Report) last posted its quarterly earnings data on Thursday, April 24th. The real estate investment trust reported $0.46 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.46. Healthpeak Properties had a return on equity of 2.61% and a net margin of 9.00%. The firm had revenue of $702.89 million during the quarter, compared to analysts' expectations of $690.76 million. During the same period in the prior year, the business earned $0.45 EPS. The company's revenue for the quarter was up 15.9% compared to the same quarter last year. Equities analysts anticipate that Healthpeak Properties, Inc. will post 1.86 EPS for the current fiscal year.

Healthpeak Properties Dividend Announcement

The company also recently disclosed a dividend, which was paid on Friday, May 30th. Stockholders of record on Tuesday, May 20th were issued a $0.1017 dividend. This represents a dividend yield of 7.05%. The ex-dividend date was Monday, May 19th. Healthpeak Properties's payout ratio is currently 305.00%.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on the stock. Scotiabank cut their price objective on shares of Healthpeak Properties from $23.00 to $21.00 and set a "sector outperform" rating for the company in a report on Monday, May 12th. Wells Fargo & Company cut their price objective on shares of Healthpeak Properties from $22.00 to $20.00 and set an "equal weight" rating for the company in a report on Monday, June 2nd. Evercore ISI cut their price target on shares of Healthpeak Properties from $23.00 to $21.00 and set an "outperform" rating for the company in a report on Monday, April 28th. Robert W. Baird decreased their price target on shares of Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating on the stock in a report on Tuesday, April 29th. Finally, Argus reissued a "buy" rating and set a $25.00 price objective on shares of Healthpeak Properties in a research note on Tuesday, April 29th. One analyst has rated the stock with a sell rating, two have given a hold rating and nine have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, Healthpeak Properties presently has a consensus rating of "Moderate Buy" and a consensus price target of $23.27.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.